Gene augmentation in FAM161A ciliopathy: Toward functional vision rescue

Mol Ther. 2023 Oct 4;31(10):2820-2822. doi: 10.1016/j.ymthe.2023.09.005. Epub 2023 Sep 19.

Authors

José-Alain Sahel¹, Katia Marazova², Deniz Dalkara²

Affiliations

¹ Department of Ophthalmology, The University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA; Sorbonne Université, INSERM, CNRS, Institut de la Vision, 75012 Paris, France; National Eye Hospital Quinze-Vingts, 75012 Paris, France; Hôpital Fondation Ophtalmologique Adolphe de Rothschild, 75019 Paris, France. Electronic address: sahelja@upmc.edu.
² Sorbonne Université, INSERM, CNRS, Institut de la Vision, 75012 Paris, France.

PMID: 37729904
PMCID: PMC10556216 (available on 2024-10-04)
DOI: 10.1016/j.ymthe.2023.09.005

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Eye Proteins / genetics
Humans
Retina
Retinitis Pigmentosa* / genetics

Substances

FAM161A protein, human
Eye Proteins

Grants and funding

P30 EY008098/EY/NEI NIH HHS/United States